Shandong Sito Bio-technology Co Ltd (300583) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Shandong Sito Bio-technology Co Ltd (300583) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.13 Million ≈ $2.21 Million USD) by net assets (CN¥1.80 Billion ≈ $263.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shandong Sito Bio-technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Shandong Sito Bio-technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300583 current and long-term liabilities for a breakdown of total debt and financial obligations.

Shandong Sito Bio-technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Sito Bio-technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Qingdao Richen Food Co Ltd
SHG:603755
0.033x
PT Temas Tbk
JK:TMAS
0.079x
Atrium Mortgage Investment Corp
TO:AI
-0.048x
THONBURI HEALTHCARE GRO-NVDR
BK:THG-R
N/A
CoAsia Microelectronics
TWO:8096
-0.504x
Nexus Real Estate Investment Trust
TO:NXR-UN
0.026x
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
0.011x
DINE S.A.B. de C.V
MX:DINEB
-0.024x

Annual Cash Flow Conversion Efficiency for Shandong Sito Bio-technology Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Sito Bio-technology Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Shandong Sito Bio-technology Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.88 Billion
≈ $275.71 Million
CN¥194.46 Million
≈ $28.46 Million
0.103x +329.60%
2023-12-31 CN¥2.07 Billion
≈ $302.24 Million
CN¥-92.85 Million
≈ $-13.59 Million
-0.045x -154.77%
2022-12-31 CN¥1.77 Billion
≈ $259.14 Million
CN¥145.34 Million
≈ $21.27 Million
0.082x -37.48%
2021-12-31 CN¥1.73 Billion
≈ $253.45 Million
CN¥227.35 Million
≈ $33.27 Million
0.131x -12.80%
2020-12-31 CN¥1.69 Billion
≈ $247.50 Million
CN¥254.60 Million
≈ $37.26 Million
0.151x +392.93%
2019-12-31 CN¥1.89 Billion
≈ $276.09 Million
CN¥57.62 Million
≈ $8.43 Million
0.031x +117.00%
2018-12-31 CN¥1.86 Billion
≈ $272.45 Million
CN¥-334.41 Million
≈ $-48.94 Million
-0.180x -2914.08%
2017-12-31 CN¥1.71 Billion
≈ $249.81 Million
CN¥10.90 Million
≈ $1.59 Million
0.006x -95.20%
2016-12-31 CN¥603.01 Million
≈ $88.24 Million
CN¥80.15 Million
≈ $11.73 Million
0.133x -22.69%
2015-12-31 CN¥506.66 Million
≈ $74.14 Million
CN¥87.10 Million
≈ $12.75 Million
0.172x -71.35%
2014-12-31 CN¥290.80 Million
≈ $42.55 Million
CN¥174.49 Million
≈ $25.53 Million
0.600x +137.69%
2013-12-31 CN¥98.83 Million
≈ $14.46 Million
CN¥24.95 Million
≈ $3.65 Million
0.252x +126.87%
2012-12-31 CN¥32.47 Million
≈ $4.75 Million
CN¥-30.50 Million
≈ $-4.46 Million
-0.939x --

About Shandong Sito Bio-technology Co Ltd

SHE:300583 China Biotechnology
Market Cap
$419.72 Million
CN¥2.87 Billion CNY
Market Cap Rank
#13456 Global
#4240 in China
Share Price
CN¥15.12
Change (1 day)
+1.96%
52-Week Range
CN¥12.93 - CN¥20.10
All Time High
CN¥50.68
About

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a me… Read more